Fosun Adgenvax Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 700

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 6

Fosun Adgenvax General Information

Description

Developer of preventative vaccines designed to address infectious diseases including rabies, influenza, pneumococcal disease, and meningococcal disease. The company develops multivalent conjugate vaccines, recombinant vaccines using insect cell lines, and inactivated and attenuated vaccines, enabling healthcare providers to prevent the spread of viral and bacterial infections across diverse patient populations.

Contact Information

Formerly Known As
Chengdu Antekin Biotechnology
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 550, Fenghuang Road
  • Shuangliu District
  • Chengdu, Sichuan 610129
  • China
+86 028
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Number 550, Fenghuang Road
  • Shuangliu District
  • Chengdu, Sichuan 610129
  • China
+86 028

Fosun Adgenvax Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fosun Adgenvax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. IPO 26-Jun-2026 Announced Generating Revenue
7. Later Stage VC (Series B) 24-Jun-2026 Completed Generating Revenue
6. Later Stage VC 11-Oct-2024 Completed Generating Revenue
5. Secondary Transaction - Private 27-Aug-2024 Completed Generating Revenue
4. Merger/Acquisition 28-Oct-2021 Completed Generating Revenue
3. Secondary Transaction - Private 28-Oct-2021 Completed Generating Revenue
2. Later Stage VC 01-Apr-2019 $44.7M $59.7M Completed Generating Revenue
1. Early Stage VC 10-Aug-2016 $15M $15M Completed Generating Revenue
To view Fosun Adgenvax’s complete valuation and funding history, request access »

Fosun Adgenvax Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fosun Adgenvax Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chengdu Bio-Town Investment Government Minority
China Resources Capital Management Corporate Venture Capital Minority
Fosun Pharma Corporation Minority
Guangzhou Yuexiu Industrial Investment Fund Management PE/Buyout Minority
Prosperico Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Fosun Adgenvax FAQs

  • When was Fosun Adgenvax founded?

    Fosun Adgenvax was founded in 2012.

  • Where is Fosun Adgenvax headquartered?

    Fosun Adgenvax is headquartered in Chengdu, China.

  • What is the size of Fosun Adgenvax?

    Fosun Adgenvax has 700 total employees.

  • What industry is Fosun Adgenvax in?

    Fosun Adgenvax’s primary industry is Pharmaceuticals.

  • Is Fosun Adgenvax a private or public company?

    Fosun Adgenvax is a Private company.

  • What is Fosun Adgenvax’s current revenue?

    The current revenue for Fosun Adgenvax is .

  • How much funding has Fosun Adgenvax raised over time?

    Fosun Adgenvax has raised $143M.

  • Who are Fosun Adgenvax’s investors?

    Chengdu Bio-Town Investment, China Resources Capital Management, Fosun Pharma, Guangzhou Yuexiu Industrial Investment Fund Management, and Prosperico Ventures are 5 of 6 investors who have invested in Fosun Adgenvax.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process